Modeling Stress-precipitated Smoking Behavior for Medication Development
Status:
Completed
Trial end date:
2021-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether guanfacine or carvedilol will attenuate the
ability of stress to precipitate smoking lapse behavior in treatment seeking and
non-treatment seeking daily smokers. Participants seeking treatment for smoking will
participate in a smoking cessation attempt after the laboratory sessions. Also looking at
gender differences.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborators:
National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institute on Drug Abuse (NIDA) Office of Research on Women's Health (ORWH)